Neurons expressing NS5A1b have decreased Kv2.1-mediated K+ currents.
Casein kinase 2 inhibition blocks K+ current modulation by NS5A1b.
Casein kinase 2 inhibition potentiates K+ currents.
Ledipasvir treatment does not block NS5A1b’s modulation of Kv2.1 function.